Abzena Recognized as a Market-Leading Antibody-Drug Conjugate CDMO in Frost & Sullivan Radar Report
17.03.2026 - 17:11:48 | prnewswire.co.uk
View original content:https://www.prnewswire.co.uk/news-releases/abzena-recognized-as-a-market-leading-antibody-drug-conjugate-cdmo-in-frost--sullivan-radar-report-302715863.html
en | boerse | 68711266 |
